$114 Million is the total value of Healthcare Value Capital, LLC's 50 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 78.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Sell | ISHARESput | $7,996,000 | -58.8% | 75,000 | -62.5% | 6.99% | -50.3% |
| ENDP | Buy | ENDO HEALTH SOLUTIONS INCput | $6,816,000 | +85.3% | 150,000 | +50.0% | 5.96% | +123.5% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $6,346,000 | +36.6% | 865,745 | +19.9% | 5.55% | +64.8% |
| MRK | Sell | MERCK & CO INC NEWcall | $5,951,000 | -35.9% | 125,000 | -37.5% | 5.20% | -22.7% |
| MDY | SPDR S&P MIDCAP 400 ETF TRput | $5,658,000 | +7.7% | 25,000 | 0.0% | 4.95% | +29.9% | |
| ANIP | New | ANI PHARMACEUTICALS INC | $5,413,000 | – | 554,088 | +100.0% | 4.73% | – |
| AUXL | Buy | AUXILIUM PHARMACEUTICALS INC | $5,178,000 | +13.4% | 284,481 | +3.6% | 4.53% | +36.8% |
| AZN | ASTRAZENECA PLCsponsored adr | $4,271,000 | +9.8% | 82,239 | 0.0% | 3.74% | +32.4% | |
| SPY | SPDR S&P 500 ETF TRput | $4,200,000 | +4.7% | 25,000 | 0.0% | 3.67% | +26.3% | |
| DGX | QUEST DIAGNOSTICS INC | $4,153,000 | +1.9% | 67,208 | 0.0% | 3.63% | +22.9% | |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDcall | $3,778,000 | -43.3% | 100,000 | -41.2% | 3.30% | -31.6% |
| MRK | Buy | MERCK & CO INC NEW | $3,190,000 | +303.8% | 67,000 | +294.1% | 2.79% | +386.7% |
| HNT | New | HEALTH NET INC | $3,170,000 | – | 100,000 | +100.0% | 2.77% | – |
| FRX | Sell | FOREST LABS INC | $3,012,000 | -14.0% | 70,382 | -17.6% | 2.63% | +3.8% |
| LLY | New | LILLY ELI & COcall | $2,517,000 | – | 50,000 | +100.0% | 2.20% | – |
| LLY | New | LILLY ELI & COput | $2,517,000 | – | 50,000 | +100.0% | 2.20% | – |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $2,306,000 | +0.4% | 45,966 | 0.0% | 2.02% | +21.1% | |
| SUPN | Sell | SUPERNUS PHARMACEUTICALS INCcall | $2,199,000 | -24.0% | 300,000 | -33.3% | 1.92% | -8.3% |
| GIVN | GIVEN IMAGING | $2,114,000 | +37.3% | 109,950 | 0.0% | 1.85% | +65.5% | |
| IPXL | New | IMPAX LABORATORIES INCcall | $1,984,000 | – | 96,900 | +100.0% | 1.74% | – |
| VPHM | New | VIROPHARMA INCput | $1,963,000 | – | 50,000 | +100.0% | 1.72% | – |
| QLTI | Buy | QLT INC | $1,922,000 | +19.9% | 415,139 | +13.7% | 1.68% | +44.7% |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDadr | $1,889,000 | – | 50,000 | +100.0% | 1.65% | – |
| CRTX | Sell | CORNERSTONE THERAPEUTICS INCcall | $1,882,000 | +10.4% | 200,000 | -6.1% | 1.65% | +33.2% |
| HUM | Sell | HUMANA INC | $1,867,000 | -44.8% | 20,000 | -50.1% | 1.63% | -33.5% |
| SLTM | New | SOLTA MED INC | $1,847,000 | – | 892,250 | +100.0% | 1.62% | – |
| AUXL | New | AUXILIUM PHARMACEUTICALS INCput | $1,820,000 | – | 100,000 | +100.0% | 1.59% | – |
| ACT | ACTAVIS INC | $1,803,000 | +14.0% | 12,524 | 0.0% | 1.58% | +37.6% | |
| SNY | SANOFIsponsored adr | $1,657,000 | -1.7% | 32,735 | 0.0% | 1.45% | +18.6% | |
| HNT | New | HEALTH NET INCcall | $1,585,000 | – | 50,000 | +100.0% | 1.39% | – |
| SGNT | Sell | SAGENT PHARMACEUTICALS INC | $1,506,000 | -30.2% | 73,822 | -28.3% | 1.32% | -15.8% |
| VVUS | Buy | VIVUS INCput | $1,395,000 | +121.8% | 150,000 | +200.0% | 1.22% | +167.5% |
| V107SC | Sell | WELLPOINT INC | $1,254,000 | -32.3% | 15,000 | -33.7% | 1.10% | -18.3% |
| TRGT | New | TARGACEPT INC | $1,076,000 | – | 202,600 | +100.0% | 0.94% | – |
| PCRX | Sell | PACIRA PHARMACEUTICALS INC | $986,000 | -24.4% | 20,500 | -54.4% | 0.86% | -8.9% |
| MDCO | New | MEDICINES COcall | $838,000 | – | 25,000 | +100.0% | 0.73% | – |
| CRY | CRYOLIFE INC | $828,000 | +11.9% | 118,288 | 0.0% | 0.72% | +34.8% | |
| BOTA | New | BIOTA PHARMACEUTIALS INC | $758,000 | – | 181,229 | +100.0% | 0.66% | – |
| STML | New | STEMLINE THERAPEUTICS INC | $746,000 | – | 16,464 | +100.0% | 0.65% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $566,000 | – | 50,000 | +100.0% | 0.50% | – |
| ZGNX | ZOGENIX INC | $511,000 | +8.0% | 276,336 | 0.0% | 0.45% | +30.3% | |
| CYTK | Sell | CYTOKINETICS INC | $429,000 | -44.4% | 56,666 | -15.0% | 0.38% | -32.9% |
| SNSS | SUNESIS PHARMACEUTICALS INC | $413,000 | -4.4% | 83,185 | 0.0% | 0.36% | +15.3% | |
| ANAC | ANACOR PHARMACEUTICALS INC | $401,000 | +90.0% | 37,730 | 0.0% | 0.35% | +129.4% | |
| ZIOP | ZIOPHARM ONCOLOGY INC | $394,000 | +86.7% | 100,000 | 0.0% | 0.34% | +125.5% | |
| FOLD | New | AMICUS THERAPEUTICS INC | $313,000 | – | 135,000 | +100.0% | 0.27% | – |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $302,000 | – | 100,000 | +100.0% | 0.26% | – |
| XNPT | New | XENOPORT INCcall | $284,000 | – | 50,000 | +100.0% | 0.25% | – |
| CRY | CRYOLIFE INCcall | $279,000 | +11.6% | 39,900 | 0.0% | 0.24% | +34.8% | |
| QLTI | New | QLT INCcall | $76,000 | – | 16,500 | +100.0% | 0.07% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INCput | $0 | – | -50,000 | -100.0% | -0.28% | – |
| ACHI | Exit | ACCRETIVE HEALTH INC | $0 | – | -49,100 | -100.0% | -0.38% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -80,315 | -100.0% | -0.43% | – |
| VNDA | Exit | VANDA PHARMACEUTICALS INCcall | $0 | – | -75,000 | -100.0% | -0.44% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG COcall | $0 | – | -10,000 | -100.0% | -0.45% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.54% | – |
| CRTX | Exit | CORNERSTONE THERAPEUTICS INC | $0 | – | -108,168 | -100.0% | -0.63% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORPcall | $0 | – | -100,000 | -100.0% | -0.67% | – |
| AZN | Exit | ASTRAZENECA PLCcall | $0 | – | -25,000 | -100.0% | -0.86% | – |
| GSK | Exit | GLAXOSMITHKLINE PLCcall | $0 | – | -25,000 | -100.0% | -0.91% | – |
| SNY | Exit | SANOFIcall | $0 | – | -25,000 | -100.0% | -0.93% | – |
| STJ | Exit | ST JUDE MED INC | $0 | – | -31,349 | -100.0% | -1.04% | – |
| MDCO | Exit | MEDICINES COput | $0 | – | -50,000 | -100.0% | -1.12% | – |
| HMA | Exit | HEALTH MGMT ASSOC INC NEWcl a | $0 | – | -100,000 | -100.0% | -1.14% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -65,588 | -100.0% | -1.18% | – |
| WCG | Exit | WELLCARE HEALTH PLANS INC | $0 | – | -30,000 | -100.0% | -1.21% | – |
| OFIX | Exit | ORTHOFIX INTL N V | $0 | – | -71,200 | -100.0% | -1.39% | – |
| FRX | Exit | FOREST LABS INCcall | $0 | – | -50,000 | -100.0% | -1.49% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INCput | $0 | – | -25,000 | -100.0% | -1.67% | – |
| AUXL | Exit | AUXILIUM PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -1.81% | – |
| BPAX | Exit | BIOSANTE PHARMACEUTICALS INC | $0 | – | -2,244,663 | -100.0% | -1.84% | – |
| TECH | Exit | TECHNE CORP | $0 | – | -40,000 | -100.0% | -2.00% | – |
| CAH | Exit | CARDINAL HEALTH INC | $0 | – | -69,886 | -100.0% | -2.39% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -677,749 | -100.0% | -2.82% | – |
| IBB | Exit | ISHARES TRput | $0 | – | -25,000 | -100.0% | -3.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-11-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.